Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2019 Financial Results

Galmed Pharma (GLMD) Tops Q2 EPS by 2c

August 5, 2019 7:09 AM EDT

Galmed Pharma (NASDAQ: GLMD) reported Q2 EPS of ($0.20), $0.02 better than the analyst estimate of ($0.22).

Financial Summary - Second Quarter 2019 vs. Second Quarter 2018

Cash and cash equivalents, short-term deposits and marketable securities totaled $83.6 million as of June 30, 2019, compared to $90.2 million at December 31,... More